Whittier Trust’s CRISPR Therapeutics CRSP Stock Holding History

Whittier Trust’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,469	Closed	-$71.4K	–	1443
2025 Q2	$71.4K	Hold	1,469	–	–	﹤0.01%	871
2025 Q1	$50K	Hold	1,469	–	–	﹤0.01%	932
2024 Q4	$57.8K	Sell	1,469 -5	-0.3%	-$236	﹤0.01%	910
2024 Q3	$69.2K	Hold	1,474	–	–	﹤0.01%	870
2024 Q2	$79.6K	Buy	1,474 +800	+119%	+$46.3K	﹤0.01%	825
2024 Q1	$45.9K	Hold	674	–	–	﹤0.01%	955
2023 Q4	$42.2K	Hold	674	–	–	﹤0.01%	955
2023 Q3	$30.6K	Hold	674	–	–	﹤0.01%	1026
2023 Q2	$37.8K	Hold	674	–	–	﹤0.01%	990
2023 Q1	$30.5K	Hold	674	–	–	﹤0.01%	1059
2022 Q4	$27.4K	Buy	674 +466	+224%	+$24.7K	﹤0.01%	1078
2022 Q3	$14K	Hold	208	–	–	﹤0.01%	1273
2022 Q2	$13K	Hold	208	–	–	﹤0.01%	1265
2022 Q1	$13K	Buy	208 +9	+5%	+$565	﹤0.01%	1286
2021 Q4	$15K	Sell	199 -924	-82%	-$80.7K	﹤0.01%	1241
2021 Q3	$126K	Hold	1,123	–	–	﹤0.01%	731
2021 Q2	$182K	Hold	1,123	–	–	﹤0.01%	675
2021 Q1	$137K	Buy	1,123 +924	+464%	+$140K	﹤0.01%	713
2020 Q4	$30K	Hold	199	–	–	﹤0.01%	951
2020 Q3	$17K	Hold	199	–	–	﹤0.01%	1036
2020 Q2	$15K	Hold	199	–	–	﹤0.01%	1009
2020 Q1	$8K	Hold	199	–	–	﹤0.01%	1133
2019 Q4	$12K	Hold	199	–	–	﹤0.01%	1101
2019 Q3	$8K	Hold	199	–	–	﹤0.01%	1169
2019 Q2	$9K	Hold	199	–	–	﹤0.01%	1086
2019 Q1	$7K	Hold	199	–	–	﹤0.01%	1101
2018 Q4	$6K	Hold	199	–	–	﹤0.01%	1151
2018 Q3	$9K	Hold	199	–	–	﹤0.01%	1050
2018 Q2	$12K	Buy	+199	New	+$11.3K	﹤0.01%	1000

Other funds holding CRSP

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Whittier Trust's CRSP Position: Q3 2025 in Review

Whittier Trust sold out of CRISPR Therapeutics (CRSP) in Q3 2025, closing a stake of 1,469 shares — an estimated $71.4K sold.

Whittier Trust first reported a position in CRSP in Q2 2018 and held it in 29 quarters. The position peaked at $182K in Q2 2021. 440 funds tracked by Wall St. Rank hold CRSP as of Q3 2025.

Whittier Trust reported no remaining CRISPR Therapeutics position as of Q3 2025 after selling out during the quarter.
Whittier Trust sold 1,469 CRISPR Therapeutics shares in Q3 2025, an estimated $71.4K.
Whittier Trust first reported a position in CRISPR Therapeutics in Q2 2018 and held it in 29 quarters.
Whittier Trust's CRISPR Therapeutics position peaked at $182K in Q2 2021.
440 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2025.

Based on Whittier Trust's 13F filing for Q3 2025, filed 31 Oct 2025.